Effect of clopidogrel plus aspirin on ST segments in patients with ST-elevation acute myocardial infarction

Mohamed Jabaren1, Devang Mahesh Desai, Abdulrahman Arabi

  • 1St. John Hospital and Medical Center, Detroit, Michigan, USA.

Insights

Early clopidogrel administration and specific angiographic factors predict spontaneous ST-segment resolution in ST-elevation myocardial infarction patients. This resolution is linked to better outcomes and preserved heart function.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • Spontaneous ST-segment resolution (STR) post-ST-elevation myocardial infarction (STEMI) correlates with improved patient outcomes.
  • The impact of modern antiplatelet and antithrombotic therapies on STR remains incompletely understood.

Purpose of the Study:

  • To identify independent clinical and angiographic predictors of STR in STEMI patients prior to percutaneous coronary intervention.
  • To evaluate the association of early antiplatelet therapy with STR.

Main Methods:

  • Retrospective analysis of 206 STEMI patients undergoing percutaneous coronary intervention.
  • Stepwise logistic regression to determine independent predictors of STR.
  • Assessment of clinical characteristics, symptom duration, ejection fraction, and angiographic findings.

Main Results:

  • STR occurred in 18% of patients (37 out of 206).
  • Independent predictors of STR included early clopidogrel administration (OR 2.10), single-vessel disease (OR 2.85), shorter chest pain duration (OR 0.98), presence of collaterals (OR 4.3), circumflex artery as culprit vessel (OR 4.74), and coronary thrombus (OR 5.76).
  • Patients with STR were younger, had shorter symptom duration, preserved ejection fraction, shorter hospital stays, and fewer arrhythmias or deaths.

Conclusions:

  • Early administration of clopidogrel is associated with and likely contributes to STR in STEMI.
  • Angiographic factors such as coronary thrombus, collateral flow, and circumflex artery involvement predict STR.
  • STR is associated with preserved left ventricular function and better in-hospital outcomes.

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...